Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a Plant-Based liquid boost liver health and ease digestion?

NCT ID NCT07673432

Disease control Sponsor: Biocol Labs Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study tests a plant-based liquid supplement in 20 adults aged 40 to 60 who have elevated liver enzymes and digestive issues. Participants take the supplement daily for 90 days, and researchers track changes in body weight, waist size, liver enzymes, cholesterol, and digestive symptoms. The goal is to see if the supplement can improve metabolic health and overall well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Plant-Based Liquid Supplement (choline bitartrate, zinc sulfate, manganese sulfate, artichoke leaf extract, fennel extract, rosemary leaf extract, L-arginine, inositol, bromelain, papain, and other ingredients)
What this could lead to
If effective, this supplement could offer a natural way to support liver health, reduce digestive discomfort, and improve metabolic markers like body weight and cholesterol.
What could go wrong
This is a very small, single-arm trial with only 20 participants and no placebo group, so results may not be reliable or generalizable. The supplement contains multiple ingredients, making it unclear which ones might be responsible for any effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Jun 2025

Finished

Jan 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 40 to 60 years * Elevated ALT or AST identified during prescreening blood testing * Currently experiencing at least two of the following: Stomach discomfort, Constipation, Diarrhea, Heartburn, Bloating, Gas, Abdominal pain, Skin redness or pimples, Sugar cravings * Willing to comply with study requirements * Willing to discontinue supplements or herbal remedies targeting detoxification, digestive health, liver function, or skin health during the study * Willing to avoid starting new products, medications, or supplements targeting detoxification, digestive health, liver function, or skin health * Willing to maintain normal diet, sleep patterns, and activity levels * Generally healthy without uncontrolled chronic disease * Resides in the United States * Not participating in another research study during the study period * Has access to a study partner to take study photographs Exclusion Criteria: * Severe digestive disorders including acid reflux, IBS, IBD, Crohn's disease, or gastrointestinal tract surgeries * Liver disease * Known allergy or hypersensitivity to study product ingredients Chronic conditions that would interfere with study participation, including oncological or psychiatric disorders * Known severe allergic reactions * Pregnant, breastfeeding, or attempting to conceive * Unwilling to follow study procedures * Stopped hormonal birth control within the past month * History of substance abuse * Use of prescription diabetes medications, including GLP-1 receptor agonists such as Ozempic, Wegovy, or Mounjaro

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Digestive symptoms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Digestive symptoms Elevated liver enzymes Metabolic health

Contacts and locations

Locations

  • Citruslabs

    Las Vegas, Nevada, 89118, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.